New COVID-19 Vaccine Errors Or Hazards
After the US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to both the Pfizer-BioNTech and Moderna coronavirus disease 2019 (COVID-19) vaccines, ISMP…
After the US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to both the Pfizer-BioNTech and Moderna coronavirus disease 2019 (COVID-19) vaccines, ISMP…
On January 12, Pfizer Inc. announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies…
Right before Christmas Pfizer Inc. and BioNTech SE announced a second agreement with the U.S. government to supply an additional 100 million doses of the…
After the approving of Pfizer-BioNTech and Moderna COVID-19 vaccines the Advisory Committee on Immunization Practices (ACIP) has issued vaccines interim clinical considerations for the prevention…
On December 18, Walgreens announced about beginning Pfizer’s COVID-19 vaccine administering to residents and staff at long-term care facilities. Pharmacists are providing the vaccinations at…
On December 10 FDA (Food and Drug Administration) holds an advisory committee meeting to discuss authorization of COVID-19 vaccine candidate (vaccine from Pfizer and Biontech)…
Recently, The U.S. Food and Drug Administration (FDA) posted online background material for this week’s upcoming Vaccines and Related Biological Products Advisory Committee (VRBPAC) public…
On November 20, Pfizer Inc. and BioNTech SE announced they will submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use…
In an open letter, October 16, Pfizer chairman and CEO Albert Bourla, announced that BioNTech COVID-19 vaccine will be ready for FDA submission by late…